Kátia Bórgia Barbosa Pagnano

Author

Universidade Estadual de Campinas (UNICAMP)ORCID

Also Known As

K B B Pagnano, K Pagnano, K. B B Pagnano, K. B. B. Pagnano, K. B. Pagnano, K. Pagnano, K.B. Pagnano, K.B.B. Pagnano, KATIA BORGIA BARBOSA PAGNANO, Katia B B Pagnano

216

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Universidade Estadual de Campinas (UNICAMP)Universidade de São Paulo Universidade Federal do Paraná Universidade Federal de Minas Gerais Universidade Federal do Rio Grande do Sul

About

Kátia Bórgia Barbosa Pagnano is an author at Universidade Estadual de Campinas (UNICAMP) specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	244
2	Health Sciences	2	2	47
3	Cell Biology	2	2	46
4	Engineering	1	1	17
5	Public Health	1	1	13

Kátia Bórgia Barbosa Pagnano

Publications

Citations

H-Index

Page 1

	Year	Citations
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL Eduardo Magalhães Rego, Haesook T. Kim, Guillermo J. Ruíz‐Argüelles, Blood	2013	148
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study Antonio R. Lucena‐Araujo, Haesook T. Kim, Rafael Henriques Jácomo, Annals of Hematology Hematological MalignancyMedicineMalignant Blood DisorderMixed-phenotype Acute LeukemiaPathology	2014	74
Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale Helen White, John Hedges, Israel Bendit, Clinical Chemistry	2013	51
p53, Mdm2, and c‐Myc overexpression is associated with a poor prognosis in aggressive non‐Hodgkin's lymphomas Kátia Bórgia Barbosa Pagnano, José Vassallo, Irene Lorand‐Metze, American Journal of Hematology	2001	48
Adherence to Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: A Brazilian Single-Center Cohort Maria Helena Almeida, Kátia Bórgia Barbosa Pagnano, Afonso Celso Vigorito, Acta Haematologica	2013	38
High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia Antonio R. Lucena‐Araujo, Haesook T. Kim, Carolina Hassibe Thomé, Blood	2015	36
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry Irène Biasoli, Nelson Castro, Márcia Torresan Delamain, International Journal of Cancer	2017	33
Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineage Bárbara da Costa Reis Monte-Mór, Isabelle Plo, Anderson Ferreira da Cunha, Leukemia Cell LineageCell RegulationCell DivisionDevelopmental GeneticsGenetics	2008	29
COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study Delphine Réa, Michael J. Mauro, Jörge E. Cortes, Blood	2020	29
Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel Carolina Pavlovsky, Virginia Abello Polo, Kátia Bórgia Barbosa Pagnano, Blood Advances Mixed-phenotype Acute LeukemiaImmunologyPathologyPharmacotherapyMyeloid Neoplasia	2021	29

Page 1